erythromycin 2'-acetate has been researched along with erythromycin ethylsuccinate in 1 studies
Studies (erythromycin 2'-acetate) | Trials (erythromycin 2'-acetate) | Recent Studies (post-2010) (erythromycin 2'-acetate) | Studies (erythromycin ethylsuccinate) | Trials (erythromycin ethylsuccinate) | Recent Studies (post-2010) (erythromycin ethylsuccinate) |
---|---|---|---|---|---|
27 | 14 | 0 | 530 | 49 | 12 |
Protein | Taxonomy | erythromycin 2'-acetate (IC50) | erythromycin ethylsuccinate (IC50) |
---|---|---|---|
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 2.0893 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.0199 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allonen, H; Elonen, E; Roos, L; Saloranta, P | 1 |
1 trial(s) available for erythromycin 2'-acetate and erythromycin ethylsuccinate
Article | Year |
---|---|
Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability.
Topics: Adolescent; Adult; Aged; Erythromycin; Erythromycin Ethylsuccinate; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Respiratory Tract Infections | 1989 |